Magnesium and the blood-brain barrier in vitro: effects on permeability and magnesium transport

被引:22
|
作者
Romeo, Valentina [1 ]
Cazzaniga, Alessandra [1 ]
Maier, Jeanette A. M. [1 ]
机构
[1] Univ Milan, Dipartimento Sci Biomed & Clin L Sacco, Via GB Grassi 74, I-20157 Milan, Italy
关键词
magnesium; blood-brain barrier; lipopolysaccharide; SULFATE; DYSFUNCTION; MODULATION; STRESS; CELLS; MODEL;
D O I
10.1684/mrh.2019.0454
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The blood-brain barrier (BBB) tightly regulates the homeostasis of the central nervous system, and its dysfunction has been described in several neurological disorders. Since magnesium exerts a protective effect in the brain, we assessed whether supraphysiological concentrations of different magnesium salts modulate the permeability and magnesium transport in in vitro models of rat and human BBB. Among various formulations tested, magnesium pidolate was the most efficient in reducing the permeability and in enhancing magnesium transport through the barrier. We then compared magnesium pidolate and magnesium sulfate, a widely used salt in experimental models and in clinical practice. Magnesium pidolate performs better than sulfate also in preventing lipopolysaccharide-induced damage to in vitro generated BBB. We conclude that magnesium pidolate emerges as an interesting alternative to sulfate to protect BBB and maintain correct intracerebral concentrations of magnesium.
引用
收藏
页码:16 / 24
页数:9
相关论文
共 50 条
  • [41] The effects of hypoglycemic and alcoholic coma on the blood-brain barrier permeability
    Yorulmaz, Hatice
    Seker, Fatma Burcu
    Oztas, Baria
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2011, 11 (02) : 108 - 112
  • [42] The effects of pentosan polysulphate on the blood-brain barrier in vitro
    Deli, M. A.
    Abraham, C. S.
    Veszelka, S.
    Niwa, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 106 - 106
  • [43] Effects of arsenolipids on in vitro blood-brain barrier model
    Mueller, S. M.
    Ebert, F.
    Raber, G.
    Meyer, S.
    Bornhorst, J.
    Huwel, S.
    Galla, H. -J.
    Francesconi, K. A.
    Schwerdtle, T.
    ARCHIVES OF TOXICOLOGY, 2018, 92 (02) : 823 - 832
  • [44] Effects of arsenolipids on in vitro blood-brain barrier model
    S. M. Müller
    F. Ebert
    G. Raber
    S. Meyer
    J. Bornhorst
    S. Hüwel
    H.-J. Galla
    K. A. Francesconi
    T. Schwerdtle
    Archives of Toxicology, 2018, 92 : 823 - 832
  • [45] Magnesium enhances the beneficial effects of NK1 antagonist administration on blood-brain barrier permeability and motor outcome after traumatic brain injury
    Ameliorate, Joshua L.
    Ghabriel, Mounir N.
    Vink, Robert
    MAGNESIUM RESEARCH, 2017, 30 (03) : 88 - 97
  • [46] Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug
    Gaillard, PJ
    de Boer, AG
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 12 (02) : 95 - 102
  • [47] In vitro effects of anaesthetic agents on the blood-brain barrier
    Fischer, S
    Renz, D
    Kleinstück, J
    Schaper, W
    Karliczek, GF
    ANAESTHESIST, 2004, 53 (12): : 1177 - 1184
  • [48] Effects of magnesium administration on brain edema and blood-brain barrier breakdown after experimental traumatic brain injury in rats
    Esen, F
    Erdem, T
    Aktan, D
    Kalayci, R
    Cakar, N
    Kaya, M
    Telci, L
    JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY, 2003, 15 (02) : 119 - 125
  • [49] Permeability of ergot alkaloids across the blood-brain barrier in vitro and influence on the barrier integrity
    Mulac, Dennis
    Huewel, Sabine
    Galla, Hans-Joachim
    Humpf, Hans-Ulrich
    MOLECULAR NUTRITION & FOOD RESEARCH, 2012, 56 (03) : 475 - 485
  • [50] Magnesium sulfate attenuates increased blood-brain barrier permeability during insulin-induced hypoglycemia and hypothermia in rats
    Kaya, M
    Kucuk, M
    Bulut, RK
    Gurses, C
    Kozanoglu, D
    Tufekci, MA
    Cevik, A
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 : 357 - 357